Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Medtronic Terminate AF Study

NCT: NCT03546374 · RECRUITING

NCT IDNCT03546374
StatusRECRUITING
Start Date2018-11-15
Completion2026-12

Brief Summary

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).

Frequently Asked Questions

What is Medtronic Terminate AF Study?

Medtronic Terminate AF Study is a clinical trial registered under NCT03546374. Current status: RECRUITING.

What is the status of NCT03546374?

The current status of NCT03546374 (Medtronic Terminate AF Study) is: RECRUITING.

When did Medtronic Terminate AF Study start?

Medtronic Terminate AF Study started on 2018-11-15.

Related Devices

PMA P100047 Ventricular (assist) bypass Medtronic

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑